全球一體化對人類健康提出了前所未有的挑戰,迫切需要培養和造就具國際水平和綜合能力的新一代領軍人才,針對關鍵的瓶頸問題,開展創新研究、改革創新體制,全面提升創新能力。生命醫學領域的創新發展,臨床研究和監管審批是兩大重要環節,共同肩負著對候選藥物和醫療器械安全性和有效性的科學評估,是龐大和復雜的系統工程,是推動創新成果轉化的根本保障。為此,清華大學醫學院與葛蘭素史克合作,共同培養清華大學“臨床研究”、“監管科學”與“人工智能”博士后。希望有志的學生們踴躍報名,開拓視野,提高能力,展示才華,為“健康中國”和世界人民的健康福祉做突出貢獻。博士后研究目標和遴選要求如下:
1.臨床研究博士后項目
1.1培養目標:臨床研究博士后項目著重培養醫學畢業生的新藥設計與研發能力,深入參與GSK的藥品臨床試驗流程,熟練掌握藥物分析中生物統計學的應用,藥代動力學評估的原理及方法等。
1.2職位要求:
·獲藥學,醫學,或理學博士學位
·熟練掌握英語
·符合清華大學博士后入站要求
1.3培養活動:
·協助GSK臨床科學家的新藥在研項目
·在GSK的不同部門進行輪轉,了解新藥研發的整體流程
·學習藥物動力學以及生物統計學等在新藥評估中的應用方法
·豐富的學術討論與交流活動
1.4培養目標:
·了解臨床研究在新藥研發中的重要性
·掌握臨床數據分析的原理與方法
·熟悉藥物分析的先進技術與局限性
·理解特殊群體臨床試驗中應設計的要素
·完成項目總結報告
2.監管科學博士后項目
2.1培養目標:監管科學博士后將與GSK的藥品監管部門以及傳染病與公共健康研究中心的工作人員一起為GSK的臨床新藥項目提供監管科學支持。
2.2職位要求:
·獲藥學,醫學,或理學博士學位
·熟練掌握英語
·符合清華大學博士后入站要求
2.3培養活動:
·了解中國藥品審批指導原則與政策
·掌握藥品研發與評估的原理及應用
·熟悉藥品IND,NDA申請的要求與方法
·研究監管政策的發展,應用,以及指導原則的解析
3.人工智能/機器學習博士后項目
3.1培養目標:人工智能/機器學習博后為初級研究人員提供了一個良好的機會,可以在兩年時間內參與AI/ML研究,以應對藥物和疫苗研發中的關鍵挑戰。博后有機會參與的這些項目,將提高我們對經過基因驗證的疾病生物學對公共衛生重要治療領域的理解。該項目除了具備一般博后項目的全部優勢以外,還能讓博后有機會與GSK的人工智能和機器學習小組專家全面接觸。
3.2職位要求:博后選拔將綜合多種因素,包括教育背景、相關經驗、職業發展目標等,另外還需要:
·符合清華大學博士后入站要求
·獲機器學習,統計,數學,計算機科學,物理學或相關定量領域的博士或碩士學位
·至少精通一種編程語言,例如Python
·能進行獨立研究
·熟練掌握英語
·具有基于機器學習的開發和應用的方法的經驗,至少一種深度學習框架(例如PyTorch,TensorFlow或Keras)的經驗。
·對人工智能的醫療/制藥應用感興趣
Global integration poses unprecedented challenges to human health, and there is an urgent need to train and produce a new generation of leaders with international standards and comprehensive capabilities, to carry out innovative research, reform innovation systems and comprehensively enhance innovation capabilities in response to key bottlenecks. Innovation and development in the field of life medicine, clinical research and regulatory approval are two important links, shouldering the scientific assessment of the safety and importance of candidate drugs and medical devices, is a huge and complex system engineering, is the fundamental guarantee to promote the transformation of innovation results. To this end, Tsinghua University School of Medicine, in collaboration with GlaxoSmithKline, has trained postdoctoral students in "clinical research" and "regulatory science" and “artificial intelligence/machine learning (AI/ML)”at
Track 1: Clinical Fellowship
Overall Goal: The Clinical Development Fellowship program is a post graduate research program with a strong emphasis on training and developing the successful Tsinghua medical school graduates who are selected to participate. The Fellows will assist GSK clinical scientists on clinical development programs of GSK compounds. They will receive all necessary GSK trainings and be assigned individual projects under the close supervision of GSK staff. The overall objective of the program is to provide post-graduate practical training or equivalent in the principles and applications of pharmaceutical product development and evaluation; research design and methodology, including development of research protocols in the clinical investigation of new drugs; and principles and applications of biostatistics, advanced pharmacokinetics, laboratory drug analysis, and study design methodology.
Track 2: Regulatory Fellowship
Overall Goal: The goal of this fellowship is to provide on-the-job practical training and experience in key regulatory functions in order to gain expertise in the regulatory requirements of drug development. The fellowship program is a post-graduate training program with a strong emphasis on attracting talents and developing successful Tsinghua candidates who are selected to participate. The Fellows will work with members of the GSK China Regulatory Department and GSK’s Institute for Infectious diseases and public health (IIDPH) to provide regulatory support for clinical development and other GSK programs. Overall this program should enhance the knowledge and real world experience of the fellow and develop a regulatory practitioner prepared for the pharmaceutical industry or academia once the fellowship is completed.
Criteria for selection of Fellows: Fellows will be selected based on education, relevant experience, and career objectives, as well as rules and regulations set forth by the
Track 3: Artificial Intelligence/Machine Learning Fellowship
Overall Goal: The GSK.ai Fellowship Program offers early-careers researchers the chance to spend two years engaged in AI/ML research applied to key challenges in drug and vaccine discovery and development. Fellows will work on projects to improve our understanding of genetically validated, disease biology for therapy areas of public health importance. The role has all the advantages of an academic posdoctoral position but with the additional benefit of having full access to GSK's artificial intelligence and machine learning group experts.
Criteria for selection of Fellows: Fellows will be selected based on education, relevant experience, and career objectives, as well as rules and regulations set forth by the
申請方式:
應聘者請將個人中英文簡歷及相關材料發送至zhangqi2013@mail.tsinghua.edu.cn。郵件主題請注明應聘清華大學“臨床研究”、“監管科學”與“人工智能”博士后 ,簡歷文件名稱請包含姓名。申請截止日期
How to apply:
Candidates are requested to send their resumes and related materials to zhangqi2013@mail.tsinghua.edu.cn. Please indicate the subject of the email to apply for
信息來源于網絡,如有變更請以原發布者為準。
來源鏈接:
https://www.med.tsinghua.edu.cn/info/1374/3890.htm
為防止簡歷投遞丟失請抄送一份至:boshijob@126.com(郵件標題格式:應聘職位名稱+姓名+學歷+專業+中國博士人才網)
中國-博士人才網發布
聲明提示:凡本網注明“來源:XXX”的文/圖等稿件,本網轉載出于傳遞更多信息及方便產業探討之目的,并不意味著本站贊同其觀點或證實其內容的真實性,文章內容僅供參考。